Skip to main content
Erschienen in: World Journal of Urology 12/2017

05.08.2017 | Original Article

Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience

verfasst von: Vincenzo Mirone, Ciro Imbimbo, Davide Arcaniolo, Marco Franco, Roberto La Rocca, Luca Venturino, Lorenzo Spirito, Massimiliano Creta, Paolo Verze

Erschienen in: World Journal of Urology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to explore the knowledge, attitudes, and practices towards prostate cancer (PCa) risk factors and prevention amongst men living in the southern Italian peninsula.

Methods

We retrospectively reviewed data collected during free preventive visits carried out by the Prevention and Research in Oncology (PRO) non-profit Foundation between July 2013 and July 2016. The following data were collected: demographic and clinical features, knowledge about PCa prevention and sources of knowledge, knowledge about PCa risk factors, previous prostate-specific antigen (PSA) test, previous digital rectal examination (DRE), previous prostate ultrasound, and general attitudes towards DRE.

Results

The study population consisted of 2144 Caucasian men living in four regions in the south of Italy (Campania, Calabria, Molise, Puglia). Median age was 59 years. One thousand six hundred and ninety-nine (79.2%) subjects reported knowing the existence of PCa prevention programs. Most of them received information from the media while only 17.1% declared that the information on PCa prevention that they received was from their family physicians. One thousand two hundred seventy-five (59.5%) subjects declared knowing of the existence of PCa risk factors and 41.3% was aware of the existence of both genetic and exogenous factors. The percentage of subjects who reported having had at least one PSA test in their life was 77.8 and 55.4% reported having had a DRE.

Conclusions

Knowledge about PCa screening amongst male subjects living in southern peninsular Italy is quite high. Knowledge of PCa risk factors is suboptimal and the practice of DRE is underutilized.
Literatur
1.
Zurück zum Zitat Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629CrossRefPubMed Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629CrossRefPubMed
2.
Zurück zum Zitat Capocaccia R, Foschi R, Zucchetto A et al (2016) Estimates of prostate cancer burden in Italy. Cancer Epidemiol 40:166–172CrossRefPubMed Capocaccia R, Foschi R, Zucchetto A et al (2016) Estimates of prostate cancer burden in Italy. Cancer Epidemiol 40:166–172CrossRefPubMed
3.
Zurück zum Zitat Schröder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384(9959):2027–2035CrossRefPubMedPubMedCentral Schröder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384(9959):2027–2035CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Pinsky PF, Prorok PC, Yu K et al (2017) Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer 123(4):592–599CrossRefPubMed Pinsky PF, Prorok PC, Yu K et al (2017) Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer 123(4):592–599CrossRefPubMed
5.
Zurück zum Zitat Rahal AK, Badgett RG, Hoffman RM (2016) Screening coverage needed to reduce mortality from prostate cancer: a living systematic review. PLoS One 11(4):e0153417CrossRefPubMedPubMedCentral Rahal AK, Badgett RG, Hoffman RM (2016) Screening coverage needed to reduce mortality from prostate cancer: a living systematic review. PLoS One 11(4):e0153417CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Arafa MA, Rabah DM, Wahdan IH (2012) Awareness of general public towards cancer prostate and screening practice in Arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev 13(9):4321–4326CrossRefPubMed Arafa MA, Rabah DM, Wahdan IH (2012) Awareness of general public towards cancer prostate and screening practice in Arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev 13(9):4321–4326CrossRefPubMed
7.
Zurück zum Zitat Zappa M, Visioli C, Crocetti E et al (2003) Practice of opportunistic PSA screening in the Florence District. Eur J Cancer Prev 12(3):201–204CrossRefPubMed Zappa M, Visioli C, Crocetti E et al (2003) Practice of opportunistic PSA screening in the Florence District. Eur J Cancer Prev 12(3):201–204CrossRefPubMed
8.
Zurück zum Zitat Cullati S, Charvet-Bérard AI, Perneger TV (2009) Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC Public Health 29(9):118CrossRef Cullati S, Charvet-Bérard AI, Perneger TV (2009) Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC Public Health 29(9):118CrossRef
9.
Zurück zum Zitat D’Ambrosio GG, Campo S, Cancian M, Pecchioli S, Mazzaglia G (2010) Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database. Eur J Cancer Prev 19(6):413–416CrossRefPubMed D’Ambrosio GG, Campo S, Cancian M, Pecchioli S, Mazzaglia G (2010) Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database. Eur J Cancer Prev 19(6):413–416CrossRefPubMed
10.
Zurück zum Zitat Inghelmann R, Grande E, Francisci S et al (2007) Regional estimates of prostate cancer burden in Italy. Tumori 93(4):380–386PubMed Inghelmann R, Grande E, Francisci S et al (2007) Regional estimates of prostate cancer burden in Italy. Tumori 93(4):380–386PubMed
11.
Zurück zum Zitat Fusco M, De Angelis R, Senatore G, Zigon G, Rossi S (2013) Estimates of cancer burden in Campania. Tumori 99(3):374–381PubMed Fusco M, De Angelis R, Senatore G, Zigon G, Rossi S (2013) Estimates of cancer burden in Campania. Tumori 99(3):374–381PubMed
13.
Zurück zum Zitat Verze P, Greco F, Scuzzarella S et al (2017) The impact of previous prostate surgery on the outcomes of laparoscopic radical prostatectomy. Minerva Urol Nefrol 69(1):76–84PubMed Verze P, Greco F, Scuzzarella S et al (2017) The impact of previous prostate surgery on the outcomes of laparoscopic radical prostatectomy. Minerva Urol Nefrol 69(1):76–84PubMed
14.
Zurück zum Zitat Imperatore V, Creta M, Di Meo S et al (2014) Transperineal repair of a persistent rectourethral fistula using a porcine dermal graft. Int J Surg Case Rep 5(11):800–802CrossRefPubMedPubMedCentral Imperatore V, Creta M, Di Meo S et al (2014) Transperineal repair of a persistent rectourethral fistula using a porcine dermal graft. Int J Surg Case Rep 5(11):800–802CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Creta M, Di Meo S, Buonopane R, Rocco B, Imperatore V (2017) Nonabsorbable polymer clip as a cause of chronic perineal pain after radical prostatectomy: description of a case treated by transperineal approach. Arch Ital Urol Androl 89(1):81–82CrossRefPubMed Creta M, Di Meo S, Buonopane R, Rocco B, Imperatore V (2017) Nonabsorbable polymer clip as a cause of chronic perineal pain after radical prostatectomy: description of a case treated by transperineal approach. Arch Ital Urol Androl 89(1):81–82CrossRefPubMed
16.
Zurück zum Zitat Allard CB, Dason S, Lusis J, Kapoor A (2012) Prostate cancer screening: attitudes and practices of family physicians in Ontario. Can Urol Assoc J 6(3):188–193CrossRefPubMedPubMedCentral Allard CB, Dason S, Lusis J, Kapoor A (2012) Prostate cancer screening: attitudes and practices of family physicians in Ontario. Can Urol Assoc J 6(3):188–193CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Weight CJ, Kim SP, Jacobson DJ, McGree ME, Karnes RJ, Sauver SSJ (2013) Men (aged 40–49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohort. Urology 82(6):1211–1217CrossRefPubMedPubMedCentral Weight CJ, Kim SP, Jacobson DJ, McGree ME, Karnes RJ, Sauver SSJ (2013) Men (aged 40–49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohort. Urology 82(6):1211–1217CrossRefPubMedPubMedCentral
18.
19.
Zurück zum Zitat Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT (2000) Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 90(10):1595–1600CrossRefPubMedPubMedCentral Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT (2000) Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 90(10):1595–1600CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Nakandi H, Kirabo M, Semugabo C et al (2013) Knowledge, attitudes and practices of Ugandan men regarding prostate cancer. Afr J Urol 19(4):165–170CrossRefPubMedPubMedCentral Nakandi H, Kirabo M, Semugabo C et al (2013) Knowledge, attitudes and practices of Ugandan men regarding prostate cancer. Afr J Urol 19(4):165–170CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat McNaughton D, Aiken W, McGrowder D (2011) Factors affecting prostate cancer screening behaviour in a discrete population of doctors at the University Hospital of the West Indies, Jamaica. Asian Pac J Cancer Prev 12(5):1201–1205PubMed McNaughton D, Aiken W, McGrowder D (2011) Factors affecting prostate cancer screening behaviour in a discrete population of doctors at the University Hospital of the West Indies, Jamaica. Asian Pac J Cancer Prev 12(5):1201–1205PubMed
22.
Zurück zum Zitat Slatkoff S, Gamboa S, Zolotor AJ, Mounsey AL, Jones K (2011) PURLs: PSA testing: when it’s useful, when it’s not. J Fam Pract 60(6):357–360PubMedPubMedCentral Slatkoff S, Gamboa S, Zolotor AJ, Mounsey AL, Jones K (2011) PURLs: PSA testing: when it’s useful, when it’s not. J Fam Pract 60(6):357–360PubMedPubMedCentral
23.
Zurück zum Zitat D’Ambrosio G, Samani F, Cancian M, De Mola C (2004) Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database. Eur J Cancer Prev 13(5):383–386CrossRefPubMed D’Ambrosio G, Samani F, Cancian M, De Mola C (2004) Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database. Eur J Cancer Prev 13(5):383–386CrossRefPubMed
24.
Zurück zum Zitat Yang JB, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM (2010) Outcome of prostate biopsy in men younger than 40 years of age with high prostate-specific antigen (PSA) levels. Korean J Urol 51(1):21–24CrossRefPubMedPubMedCentral Yang JB, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM (2010) Outcome of prostate biopsy in men younger than 40 years of age with high prostate-specific antigen (PSA) levels. Korean J Urol 51(1):21–24CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Madu CO, Lu Y (2010) Novel diagnostic biomarkers for prostate cancer. J Cancer 6(1):150–177CrossRef Madu CO, Lu Y (2010) Novel diagnostic biomarkers for prostate cancer. J Cancer 6(1):150–177CrossRef
26.
Zurück zum Zitat Nagler HM, Gerber EW, Homel P et al (2005) Digital rectal examination is barrier to population-based prostate cancer screening. Urology 65(6):1137–1140CrossRefPubMed Nagler HM, Gerber EW, Homel P et al (2005) Digital rectal examination is barrier to population-based prostate cancer screening. Urology 65(6):1137–1140CrossRefPubMed
27.
Zurück zum Zitat Bynum J, Song Y, Fisher E (2010) Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service medicare. J Am Geriatr Soc 58(4):674–680CrossRefPubMedPubMedCentral Bynum J, Song Y, Fisher E (2010) Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service medicare. J Am Geriatr Soc 58(4):674–680CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Littrup PJ, Bailey SE (2000) Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin N Am 38(1):87–113CrossRefPubMed Littrup PJ, Bailey SE (2000) Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin N Am 38(1):87–113CrossRefPubMed
29.
Zurück zum Zitat Tonttila PP, Lantto J, Pääkkö E, Piippo U et al (2016) Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol 69(3):419–425CrossRefPubMed Tonttila PP, Lantto J, Pääkkö E, Piippo U et al (2016) Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol 69(3):419–425CrossRefPubMed
30.
Zurück zum Zitat Ahmed HU, El-Shater Bosaily A, Brown LC, PROMIS study group et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRefPubMed Ahmed HU, El-Shater Bosaily A, Brown LC, PROMIS study group et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRefPubMed
Metadaten
Titel
Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience
verfasst von
Vincenzo Mirone
Ciro Imbimbo
Davide Arcaniolo
Marco Franco
Roberto La Rocca
Luca Venturino
Lorenzo Spirito
Massimiliano Creta
Paolo Verze
Publikationsdatum
05.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-017-2074-9

Weitere Artikel der Ausgabe 12/2017

World Journal of Urology 12/2017 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.